Batrachochytrium Dendrobatidis - Immunity Hypotheses

Immunity Hypotheses

Due to the fungus' immense impact on amphibian populations, considerable research has been undertaken to devise methods to combat its proliferation. Among the most promising is the revelation that amphibians in colonies that survive the passage of the chytrid epidemic tend to carry higher levels of the bacterium Janthinobacterium lividum. This bacterium produces antifungal compounds, such as indole-3-carboxaldehyde and violacein, that inhibit the growth of B. dendrobatidis even at low concentrations. Similarly, the bacterium Lysobacter gummosus found on the red-backed salamander (Plethodon cinereus), produces the compound 2,4-diacetylphloroglucinol that is inhibitory to the growth of B. dendrobatidis.

Understanding the interactions of microbial communities present on amphibians’ skin with fungal species in the environment can reveal why certain amphibians, such as the frog Rana muscosa, are susceptible to the fatal effects of B. dendrobatidis and why others, such as the salamander Hemidactylium scutatum, are able to coexist with the fungus. As mentioned before, the antifungal bacterial species Janthinobacterium lividum, found on several amphibian species, has been shown to prevent the effects of the pathogen even when added to another amphibian that lacks the bacteria (B. dendrobatidis-susceptible amphibian species). Interactions between cutaneous microbiota and B. dendrobatidis can be altered to favor the resistance of the disease, as seen in past lab studies concerning the addition of the violacein-producing bacteria J. lividum to amphibians that lacked sufficient violacein, allowing them to inhibit infection. Although the exact concentration of violacein (antifungal metabolite produced by J. lividum) needed to inhibit the effects of B. dendrobatidis is not fully confirmed, violacein concentration can determine whether or not an amphibian will experience morbidity (or mortality) caused by the chytrid fungus B. dendrobatidis. The frog Rana muscosa, for example, has been found to have very low concentrations of violacein on its skin, yet the concentration is so small that it is unable to facilitate increased survivability of the frog; furthermore, Janthinobacterium lividum has not been found to be present on the skin of Rana muscosa. This implies that the antifungal bacteria J. lividum (native to other amphibians' skin, such as Hemidactylium scutatum) is able to produce a sufficient amount of violacein to prevent infection by B. dendrobatidis and allow coexistence with the potentially deadly fungus.

Studies conducted by Dr. Reid Harris and colleagues of the Department of Biology of James Madison University in Virginia have shown that the addition of the anti-chytrid (antifungal) bacteria Janthinobacterium lividum to the skin of B. dendrobatidis-susceptible amphibians (i.e. Rana muscosa juveniles) increases the concentration of the antifungal metabolite violacein, which in turn decreases the mortality rate due to infection by B. dendrobatidis and also increases survivability. The removal of resident skin bacteria of the amphibians precedes the application of Janthinobacterium lividum and exposure to B. dendrobatidis zoospores (in the majority of experiments that have been previously been conducted), which reduces bacterial species on the amphibians' skin and also reduces possible interactions between J. lividum and other species of bacteria present on the skin. This allows for a standard condition of the amphibians’ skin that can then be compared to the J. lividum treatment of an experiment, thereby yielding simpler and more attributable survival/inhibition results concerning the newly added bacterial species (J. lividum). To reiterate, the majority of research done in this area has been concerned with prevention by applying J. lividum to amphibians before infection (by B. dendrobatidis) and after removal of their original skin bacteria. However, little research has been conducted to see if the addition of Janthinobacterium lividum without initial removal of the amphibians’ cutaneous microbiota is still as effective against the pathogen. Further research is needed to explore conditions and treatments that will include the original cutaneous bacterial species of the amphibians (that is to say, excluding the bacterial removal procedures commonly done before applying the antifungal bacteria) that will determine whether or not the addition of J. lividum will still increase survivability by inhibiting the fungus even without the initial removal of the resident skin bacteria. This would allow for a more practical method of bioaugmentation when treating a B. dendrobatidis-susceptible amphibian population in nature.

A recent study has postulated that Daphnia magna eats the spores of the fungus.